Neutrophil–Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel:	Journal of Clinical Laboratory Analysis
Personen und Körperschaften:	Gökmen, Ferhat, Akbal, Ayla, Reşorlu, Hatice, Gökmen, Esra, Güven, Mustafa, Aras, Adem Bozkurt, Erbağ, Gökhan, Kömürcü, Erkam, Akbal, Erdem, Coşar, Murat
In:	Journal of Clinical Laboratory Analysis, 29, 2015, 4, S. 294-298
Format:	E-Article
Sprache:	Englisch
veröffentlicht:	Wiley
Schlagwörter:	Microbiology (medical) Biochemistry (medical) Medical Laboratory Technology Clinical Biochemistry Public Health, Environmental and Occupational Health Hematology Immunology and Allergy

Details
Zusammenfassung:	<jats:sec><jats:title>Background</jats:title><jats:p>In recent years, white blood cells (WBCs) and their subtypes have been studied in relation to inflammation. The aim of our study was to assess the relationship between neutrophil–lymphocyte ratio (NLR) and ankylosing spondylitis (AS).</jats:p></jats:sec><jats:sec><jats:title>Materials and methods</jats:title><jats:p>We enrolled a total of 177 patients, 96 AS and 81 healthy controls. Complete blood count, WBC, neutrophil and lymphocyte levels were measured, and the NLR was calculated. In the assessment of AS, we used the erythrocyte sedimentation rate, C‐reactive protein (CRP), the Bath Ankylosing Spondylitis Disease Activity Index, and the Bath Ankylosing Spondylitis Functional Index.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, 96 AS and 81 healthy individuals were enrolled. The mean age was 43.8 ± 12.9 and 46.5 ± 11.2 years, respectively. Mean disease duration of AS patients was 6.9 ± 5.6 years (median = 5, min–max = 1–25). The patients with AS had a higher NLR than the control individuals (mean NLR, 2.24 ± 1.23 and 1.73 ± 0.70, respectively, <jats:italic>P</jats:italic> < 0.001). A statistically significant positive correlation was observed between NLR and CRP (<jats:italic>r</jats:italic> = 0.322, <jats:italic>P</jats:italic> = 0.01). The patients receiving antitumor necrosis factor α therapy had a lower NLR than the patients receiving nonsteroidal anti‐inflammatory drug therapy (mean NLR, 1.71 ± 0.62 and 2.41 ± 1.33, respectively, <jats:italic>P</jats:italic> = 0.02).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>NLR may be seen as a useful marker for demonstrating inflammation together with acute phase reactants such as CRP and in evaluating the effectiveness of anti‐TNF‐α therapy.</jats:p></jats:sec>
Umfang:	294-298
ISSN:	0887-8013 1098-2825
DOI:	10.1002/jcla.21768